Lee, H.J., Jeong, G., Li, H., Kim, M., Kim, J., Park, S.J., Han, Y.J., Lee, K.H., Kronbichler, A., Hong, S.H., Ghayda, R.A., Luchini, C., Nottegar, A., Koyanagi, A., Smith, L., Jacob, L., Dragioti, E., Radua, J., Cargnin, S., Terrazzino, S., Thompson, T. ORCID: 0000-0001-9880-782X , Yon, D.K., Lee, S.W., Yang, J.M., Wasuwanich, P., Shin, J.L. and Gamerith, G. (2021) Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis. European Review for Medical and Pharmacological Sciences, 25 (20). pp. 6232-6244. ISSN 1128-3602 (doi:https://doi.org/10.26355/eurrev_202110_26993)